NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Auspex Pharmaceuticals Inc. (Nasdaq: ASPX) (“Auspex Pharmaceuticals” or “the Company”) in connection with the sale of the Company to Teva Pharmaceutical Industries Ltd.
Click here to learn about the case: http://docs.wongesq.com/ASPX-Info-Request-Form-665. There is no cost or obligation to you.
Under the terms of the transaction, Auspex Pharmaceuticals shareholders will receive $101 in cash for each share of Auspex Pharmaceuticals stock they own. The investigation concerns whether the Board of Auspex Pharmaceuticals breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Teva Pharmaceutical Industries Ltd. is underpaying for Auspex Pharmaceuticals shares.
If you own common stock in Auspex Pharmaceuticals and wish to obtain additional information, please contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or visit http://docs.wongesq.com/ASPX-Info-Request-Form-665.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.